Skip to content
healthcare.dev

NYSTATIN

NDC 69315-504, NYSTATIN, suspension, from Leading Pharma, LLC.

Product NDC
69315-504
Status
Listed
Labeler
Leading Pharma, LLC
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214346
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69315-504 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NYSTATIN100000 [USP'U]/mL

Pharmacologic classes

Polyene Antifungal [EPC]; Polyenes [CS]

Package NDCNDC-11Package
69315-504-4769315050447473 mL in 1 BOTTLE (69315-504-47)
69315-504-60693150504601 BOTTLE in 1 PACKAGE (69315-504-60) / 60 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/954205d8-47ba-4c89-95cd-f0066a514cf9
  • NADAC price for package 69315050447

    GET /v1/drugs/nadac/69315050447
  • NADAC price for package 69315050460

    GET /v1/drugs/nadac/69315050460

Use it

Look up 69315-504 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69315-504 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69315-504. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.